Glucantime reduces mechanical hyperalgesia in cutaneous leishmaniasis and complete Freund's adjuvant models of chronic inflammatory pain

Leishmania infection: painful or painless?

(2016) Sergio M. Borghi et al.   PARASITOLOGY RESEARCH

Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB

(2015) Kenji W. Ruiz-Miyazawa et al.   CHEMICO-BIOLOGICAL INTERACTIONS

The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway

(2015) Sharon Rose Aragão Macedo et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice

(2015) Suelen S. da Silva et al.   PARASITOLOGY RESEARCH

Ex Vivo Host and Parasite Response to Antileishmanial Drugs and Immunomodulators

(2015) Laura Gonzalez-Fajardo et al.   PLoS Neglected Tropical Diseases

Nitric Oxide and Brazilian Propolis Combined Accelerates Tissue Repair by Modulating Cell Migration, Cytokine Production and Collagen Deposition in Experimental Leishmaniasis

(2015) Milena Menegazzo Miranda et al.   PLoS One

IL-10 Cytokine Released from M2 Macrophages Is Crucial for Analgesic and Anti-inflammatory Effects of Acupuncture in a Model of Inflammatory Muscle Pain

(2014) Morgana D. da Silva et al.   MOLECULAR NEUROBIOLOGY

Sustained Pain-Related Depression of Behavior: Effects of Intraplantar Formalin and Complete Freund's Adjuvant on Intracranial Self-Stimulation (ICSS) and Endogenous kappa Opioid Biomarkers in Rats

(2014) Michael D Leitl et al.   Molecular Pain

In Leishmania major-induced inflammation, interleukin-13 reduces hyperalgesia, down-regulates IL-1β and up-regulates IL-6 in an IL-4 independent mechanism1This project was mainly funded by the Balamand Research Grant.1

(2013) Marc C. Karam et al.   EXPERIMENTAL PARASITOLOGY

The endogenous cytokine profile and nerve fibre density in mouse ear Leishmania major-induced lesions related to nociceptive thresholds

(2012) Silvia D. Cangussú et al.   EXPERIMENTAL PARASITOLOGY

Leishmaniasis: an update of current pharmacotherapy

(2012) Shyam Sundar et al.   EXPERT OPINION ON PHARMACOTHERAPY

Interleukin-13 reduces hyperalgesia and the level of interleukin-1β in BALB/c mice infected with Leishmania major with an up-regulation of interleukin-6

(2011) Marc C. Karam et al.   JOURNAL OF NEUROIMMUNOLOGY

Potential utility of hyperbaric oxygen therapy and propolis in enhancing the leishmanicidal activity of glucantime

(2011) Diana Copi Ayres et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

Role of chemokines in regulation of immunity against leishmaniasis

(2010) Steve Oghumu et al.   EXPERIMENTAL PARASITOLOGY

Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis

(2010) Ana P. Campanelli et al.   HUMAN IMMUNOLOGY

Pentavalent Antimonials: New Perspectives for Old Drugs

(2009) Frédéric Frézard et al.   MOLECULES

Leishmania major: Interleukin-13 increases the infection-induced hyperalgesia and the levels of interleukin-1β and interleukin-12 in rats

(2008) Marc E. Haber et al.   EXPERIMENTAL PARASITOLOGY

Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-α production, but only via TNF-α it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro

(2008) Maria Imaculada Muniz-Junqueira et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis

(2008) Bernardo Acácio Santini Pereira et al.   VETERINARY PARASITOLOGY